Literature DB >> 31378893

LncRNA HAGLROS accelerates the progression of lung carcinoma via sponging microRNA-152.

W-L Wang1, D-J Yu, M Zhong.   

Abstract

OBJECTIVE: The aim of this study was to analyze the expression profiling of long non-coding RNA (lncRNA) HAGLROS and microRNA-152 in lung carcinoma (LCa), and to explore their regulatory effects on the malignant progression of LCa. PATIENTS AND METHODS: The expression of HAGLROS in 44 paired LCa tissues and matched adjacent tissues was determined by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The correlation between HAGLROS expression and clinical indexes of LCa patients was analyzed. Furthermore, HAGLROS expression in LCa cell lines was detected as well. The HAGLROS over-expression and knockdown models were established in A549 and SPC-A1 cells by transfection of pcDNA-HAGLROS and anti-HAGLROS, respectively. The biological influences of HAGLROS on LCa cells were evaluated through a series of functional experiments. Furthermore, the potential relationship between HAGLROS and microRNA-152 was analyzed.
RESULTS: HAGLROS was highly expressed in LCa tissues compared with adjacent normal tissues. LCa patients with a higher expression of HAGLROS presented significantly worse tumor stage, a higher rate of lymphatic metastasis, and a lower survival. The knockdown of HAGLROS significantly attenuated the proliferative and migratory abilities of LCa cells. Meanwhile, HAGLROS over-expression obtained the opposite results. MicroRNA-152 was negatively correlated with HAGLROS in LCa. Rescue experiments showed that the knockdown of microRNA-152 reversed the regulatory effects of HAGLROS on proliferative and migratory abilities of LCa cells.
CONCLUSIONS: HAGLROS expression is correlated with tumor stage and lymphatic metastasis of LCa patients. Furthermore, HAGLROS accelerates proliferation and migration of LCa cells by regulating microRNA-152.

Entities:  

Year:  2019        PMID: 31378893     DOI: 10.26355/eurrev_201908_18538

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  Knockdown of lncRNA HAGLROS inhibits metastasis and promotes apoptosis in nephroblastoma cells by inhibition of autophagy.

Authors:  Pugui Li; Kun Zhang; Shijie Tang; Weizhu Tang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

2.  LncRNA LINC00511 plays an oncogenic role in lung adenocarcinoma by regulating PKM2 expression via sponging miR-625-5p.

Authors:  Jinghui Xue; Fayan Zhang
Journal:  Thorac Cancer       Date:  2020-07-27       Impact factor: 3.500

3.  Long non-coding RNA HAGLROS promotes the development of diffuse large B-cell lymphoma via suppressing miR-100.

Authors:  Ling Shu; Kun Guo; Zeng-Hua Lin; Hong Liu
Journal:  J Clin Lab Anal       Date:  2021-12-09       Impact factor: 2.352

4.  Effects and early diagnostic value of lncRNA H19 on sepsis-induced acute lung injury.

Authors:  You Zhou; Liqun Sun; Mingyu Zhu; He Cheng
Journal:  Exp Ther Med       Date:  2022-02-14       Impact factor: 2.447

5.  The best protection is early detection: Fostering timely and accurate screening.

Authors:  Aila Akosua Kattner
Journal:  Biomed J       Date:  2022-01-15       Impact factor: 7.892

6.  Long Noncoding RNA HAGLROS Promotes Cell Invasion and Metastasis by Sponging miR-152 and Upregulating ROCK1 Expression in Osteosarcoma.

Authors:  Kaifeng Zhou; Jun Xu; Xiaofan Yin; Jiangni Xia
Journal:  Comput Math Methods Med       Date:  2020-09-09       Impact factor: 2.238

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.